Once medical science can extend life expectancy by more than one year per calendar year, we will reach a point where individuals outpace aging indefinitely. This concept transforms the fight against aging from a purely biological battle into a technological race against time.

Claims about extending human lifespan are fundamentally unprovable. A scientifically valid study would require observing subjects for their entire lives under controlled conditions, which is impossible. Cellular mechanisms in a lab do not reliably translate to complex human systems over decades. The goal should be increasing healthspan, not lifespan.

Near-immortality will not come from a single pill. It will be achieved by reaching "escape velocity"—the point where medical advancements extend your life expectancy by more than one year for every calendar year you live. This creates a perpetual extension of life, with death primarily coming from trauma.

While the wealthy can access expensive protocols involving diagnostics and lifestyle optimization, these offer only marginal benefits. True, effective longevity will not come from this but from validated, mass-produced biotech drugs that target the core mechanisms of aging.

The surge in longevity funding from tech billionaires stems from their mindset of viewing life as a hackable software problem. Accustomed to immense power and control, they see death as the ultimate challenge to conquer, not just a biological inevitability.

A major transformation has occurred in longevity science, particularly in the last eight years. The conversation has moved away from claims of radical life extension towards the more valuable goal of increasing "healthspan"—the period of healthy, functional life. This represents a significant and recent shift in scientific consensus.

The current medical model, which treats diseases one by one as they appear, is flawed for an aging population. It extends life but leads to a rise in overall frailty and disability. The only effective path forward is to directly target the underlying biological process of aging to extend healthspan.

While foundational, lifestyle improvements have a ceiling. The next major breakthroughs in extending health and lifespan, achieving "longevity escape velocity," will be delivered by advanced biotech like cellular reprogramming, not by the mass adoption of perfect diet, sleep, and exercise habits.

The common aversion to living to 120 stems from assuming extra years will be spent in poor health. The goal of longevity science is to extend *healthspan*—the period of healthy, mobile life—which reframes the debate from merely adding years to adding high-quality life.